These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 5332590)
41. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris. Frick MH; Katila M Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719 [No Abstract] [Full Text] [Related]
42. [A new beta-blockader, LB-46 (Visken): electrocardiographic control of its therapeutic action in angina patients]. Saner R Therapie; 1970; 25(2):393-501. PubMed ID: 4403159 [No Abstract] [Full Text] [Related]
43. [Classification of anti-angina drugs]. Schmitt H; Laubie M Therapie; 1970; 25(2):199-208. PubMed ID: 4403155 [No Abstract] [Full Text] [Related]
44. [New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease]. Musial W; Tracz W; KrzemiĆska-Pakula M Pol Tyg Lek; 1971 May; 26(22):834-6. PubMed ID: 4397439 [No Abstract] [Full Text] [Related]
45. [FIRST RESULTS OF PLANNED CLINICAL EXPERIMENTATION IN ANGINA PECTORIS OF A DRUG WITH BETA-ADRENERGIC BLOCKING ACTION]. DALLAVALLE L; BOTTI G; VISIOLI O Clin Ter; 1965 Jun; 33():523-9. PubMed ID: 14341686 [No Abstract] [Full Text] [Related]
46. Antianginal drugs. VI. Beta-adrenergic blocking agents. Fisch S Am Heart J; 1966 Jul; 72(1):131-3. PubMed ID: 5942937 [No Abstract] [Full Text] [Related]
47. Beta blocking agents for treatment of arrhythmias and angina. Irving DW Manit Med Rev; 1966 Nov; 46(9):571-2. PubMed ID: 5342201 [No Abstract] [Full Text] [Related]
48. [Use of a pure beta-blockador, 1-(4-nitrophenyl)-2-isopropylamino-ethanol in angina pectoris]. Gasparotto G; Pagnan A Folia Cardiol; 1969; 28():40-3. PubMed ID: 4397999 [No Abstract] [Full Text] [Related]
49. [Exercise tolerance in patients with angina pectoris with the beta blockader alprenol]. Liljedal J Tidsskr Nor Laegeforen; 1971 Jul; 91(19):1451-8. PubMed ID: 4398226 [No Abstract] [Full Text] [Related]
50. Indications and limits of cardiac beta-receptor blockase: physiopharmacological and clinical considerations on the subject of beta-adrenergic receptor blockade, pure and otherwise. Dotti F; Piva M; Ongari R Arzneimittelforschung; 1968 Nov; 18(11):1445-8. PubMed ID: 5755911 [No Abstract] [Full Text] [Related]
51. [Treatment of angina pectoris and arrthymias with a beta receptor blockader]. Willems D; Frisch P; Klepzig H Z Kreislaufforsch; 1971 Apr; 60(4):309-18. PubMed ID: 4397060 [No Abstract] [Full Text] [Related]
52. [Test of a new beta-blocking agent, LB 46, in the therapy of angina pectoris]. Yigitbasi O; Nalbantgil I Schweiz Rundsch Med Prax; 1970 Aug; 59(34):1218-21. PubMed ID: 4998107 [No Abstract] [Full Text] [Related]
53. [Therapy of coronary insufficiency with beta-adrenergic blocking agents]. De Maestri C; Rinaldi AR Boll Soc Med Chir Cremona; 1967; 21(3):125-32. PubMed ID: 5597563 [No Abstract] [Full Text] [Related]
54. [Beta blockers in stable angina pectoris]. Fluri M; Meier B Praxis (Bern 1994); 1995 Mar; 84(10):288-95. PubMed ID: 7892549 [TBL] [Abstract][Full Text] [Related]
55. [Treatment of angina pectoris with Trasicor (CIBA 39089-Ba)]. Lorenzen J Nord Med; 1970 Jun; 83(25):783-5. PubMed ID: 4393479 [No Abstract] [Full Text] [Related]
56. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged]. Gatti A; Scotti G Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306 [No Abstract] [Full Text] [Related]